Releases
-
New research documents how COVID-19 multiplies stress and trauma for people with disabilities
A November article published in Rehabilitation Psychology reviews research on disabilities and COVID-19 to help rehabilitation psychologists mitigate the effects of the added stress of the pandemic. In addition, the work addresses how systemic discrimination against people with disabilities intersects with other forms of inequity. Read MoreNov 4, 2020
-
Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
Nov 3, 2020
-
ĢƵ Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
Nov 2, 2020
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.
Nov 2, 2020
-
Angelika Amon, PhD, a pioneering cell and molecular biologist and winner of the 2018 ĢƵ Prize in Biomedical Science, died Oct. 29 from cancer. She was 53.
Oct 30, 2020
-
An innovative ĢƵ program that brings together scientists and artists with the shared goal of scientific communication is set to expand with support from a three-year grant from the Burroughs Wellcome Fund.
Oct 29, 2020
-
Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction.
Oct 29, 2020
-
ĢƵ epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo.
Oct 29, 2020
-
ĢƵ trans-institutional team shows how next-gen wearable sensor algorithms powered by machine learning could be key to preventing injuries that sideline runners
An interdisciplinary team of researchers led by Karl Zelik explores how wearable sensor technology can monitor bone stress in runners, developing a new multi-sensor algorithm that could save runners from months of pain and recovery time. Read MoreOct 28, 2020
-
ĢƵ anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read MoreOct 27, 2020
-
ĢƵ Genetics Institute investigators have added a new method to the computational genetics toolbox. Their approach, described in the journal Nature Genetics, integrates vast genomics datasets to predict gene expression and facilitate discovery of genetic mechanisms underlying human diseases.
Oct 22, 2020
-
A new method that keeps microbes and gut cells together will be useful for studies of complex host-microbe interactions and for analysis of clinical specimens.
Oct 20, 2020
-
Older depressed adults show accelerated brain aging, according to a new study from ĢƵ researchers, who suggest that the effects of depression may speed the decline in cognitive functions in older individuals.
Oct 19, 2020
-
ĢƵ researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth
Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read MoreOct 15, 2020
-
Researchers at ĢƵ Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori.
Oct 15, 2020
-
The brain’s response to low oxygen — growth and remodeling of blood vessels — involves certain cell types and molecular pathways, ĢƵ researchers have discovered.
Oct 15, 2020
-
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by ĢƵ Medical Center and optimized by AstraZeneca.
Oct 13, 2020
-
A computer-based method developed at ĢƵ Medical Center that scans electronic medical records (EMRs) for genetic contributors to disease has been used for the first time to reveal the impact of race on health.
Oct 8, 2020
-
Researchers at ĢƵ Medical Center have generated the first comprehensive molecular “atlas” of genes expressed by the neuronal cells within the intestine that coordinate the functions of the gastrointestinal (GI) tract.
Oct 8, 2020